Powered by
Ohio extends rebates to agencies for drug antidote Opioid epidemic
Mar 3, 2017 - Plain Dealer (Cleveland, Ohio)

Columbus — The Ohio Attorney General’s Office announced a one-year extension of a program that has saved state and local agencies almost $400,000 on naloxone, a life-saving opioid overdose antidote.

The program, a partnership between Attorney General Mike DeWine’s office and Amphastar Pharmaceuticals, will continue to offer $6 rebates on naloxone syringes through March 2, 2018, the attorney general’s office said in a news release.

The announcement comes as state and local age

Sign up for unrestricted access to 200+ subscription services.
Already have an account? Click here to login.

RelSci News & Alerts gets you:

  • 5 free articles a month from top subscription outlets like the Financial Times, New York Times, and Washington Post
  • Competitive business intelligence through daily data updates
  • Custom feeds on target high-value individuals, companies, industries, and topics delivered straight to your inbox